Artelo BiosciencesARTL
13F holders, Q3 2025 (September 30)9holders
3new positions
3sold out
$4.59avg. 13F price*
At the end of Q3 2025, 9 institutions reported holding Artelo Biosciences Inc. (ARTL) in their 13F filings, unchanged from Q2 2025. 3 opened new positions and 3 sold out. The largest holders were DRW Securities, LLC ($79K), Vanguard Group Inc. ($64K) and Morgan Stanley ($5K).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G607
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $143K |
| Exits | 3 | $219K |
All 13F filers, Q2 2025 → Q3 2025: 32,934 shares bought and 16,480 shares sold, net +16,454 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| DRW Securities, LLC | 0.00% | New | 17,185 | $79K |
| Vanguard Group Inc. | 0.00% | New | 14,028 | $64K |
| Morgan Stanley | 0.00% | Add +27400.0% | 1,100 | $5K |
| Citigroup Inc. | 0.00% | Add +5200.0% | 477 | $2K |
| UBS Group AG | 0.00% | Add +134.8% | 209 | $959 |
| FMR LLC | 0.00% | Add +2900.0% | 30 | $138 |
| Bank of America Corp. | 0.00% | Add +120.0% | 11 | $50 |
| Rothschild Investment LLC | 0.00% | New | 2 | $9 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is ARTL's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.